Skip to main content

New Alzheimer's Vaccine Begins Clinical Trial - MEDizzy Journal

Researchers have begun recruiting volunteers for the phase 1B clinical trial of the new Alzheimer’s vaccine, ALZ-101. The Swedish biopharma company, Alzinova AB has developed an Alzheimer’s vaccine that directly targets amyloid-beta oligomers within patients.

New Alzheimer's Vaccine Begins Clinical Trial - MEDizzy Journal
Labels:

Comments

Post a Comment

Popular posts from this blog

GPT-J is self-hosted open-source analog of GPT-3: how to run in Docker

Generative Pre-trained Transformer is a generation of models used to produce human-like text based on some initial text (part of dialogs or some task). One of the most "hyped" models is a GPT-3. When you see what GPT-3 generates you feel like "the future is here". GPT-J is self-hosted open-source analog of GPT-3: how to run in Docker
1 comment
Read more